Veracyte, Inc. (VCYT)
39.75
-0.39
(-0.97%)
USD |
NASDAQ |
Sep 16, 10:52
Veracyte Enterprise Value : 2.781B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 2.781B |
| September 14, 2026 | 2.867B |
| September 11, 2026 | 2.839B |
| September 10, 2026 | 2.933B |
| September 09, 2026 | 3.080B |
| September 08, 2026 | 2.966B |
| September 04, 2026 | 2.973B |
| September 03, 2026 | 3.145B |
| September 02, 2026 | 3.162B |
| September 01, 2026 | 3.045B |
| August 31, 2026 | 3.026B |
| August 28, 2026 | 3.038B |
| August 27, 2026 | 3.191B |
| August 26, 2026 | 3.114B |
| August 25, 2026 | 3.094B |
| August 24, 2026 | 2.888B |
| August 21, 2026 | 2.955B |
| August 20, 2026 | 2.913B |
| August 19, 2026 | 2.945B |
| August 18, 2026 | 2.824B |
| August 17, 2026 | 2.937B |
| August 14, 2026 | 2.870B |
| August 13, 2026 | 2.978B |
| August 12, 2026 | 3.146B |
| August 11, 2026 | 3.285B |
| Date | Value |
|---|---|
| August 10, 2026 | 3.273B |
| August 07, 2026 | 3.350B |
| August 06, 2026 | 3.264B |
| August 05, 2026 | 3.264B |
| August 04, 2026 | 3.285B |
| August 03, 2026 | 3.159B |
| July 31, 2026 | 3.277B |
| July 30, 2026 | 4.359B |
| July 29, 2026 | 4.032B |
| July 28, 2026 | 4.027B |
| July 27, 2026 | 4.024B |
| July 24, 2026 | 4.104B |
| July 23, 2026 | 4.206B |
| July 22, 2026 | 4.217B |
| July 21, 2026 | 4.339B |
| July 20, 2026 | 4.157B |
| July 17, 2026 | 4.307B |
| July 16, 2026 | 4.314B |
| July 15, 2026 | 4.337B |
| July 14, 2026 | 4.105B |
| July 13, 2026 | 4.174B |
| July 10, 2026 | 4.133B |
| July 09, 2026 | 4.320B |
| July 08, 2026 | 4.065B |
| July 07, 2026 | 4.068B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teleflex, Inc. | 8.025B |
| West Pharmaceutical Services, Inc. | 25.58B |
| Globus Medical, Inc. | 9.544B |
| Illumina, Inc. | 34.92B |
| Twist Bioscience Corp. | 8.582B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 25.49M |
| Revenue (Quarterly) | 150.32M |
| Total Expenses (Quarterly) | 124.83M |
| EPS Diluted (Quarterly) | 0.3106 |
| Gross Profit Margin (Quarterly) | 71.93% |
| Profit Margin (Quarterly) | 16.96% |
| Earnings Yield | 3.55% |
| Operating Earnings Yield | 3.00% |
| Normalized Earnings Yield | 3.246 |